The new research platform, developed by Merck and Accenture, will allow life sciences researchers and informatics professionals to quickly aggregate, access and analyse research data from multiple applications.
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organisations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development.
The new research platform, being developed by Merck and Accenture, will enable an ecosystem that accelerates innovation by creating open, industry-standard application programming interfaces for core research functions, allowing researchers to rapidly adopt new capabilities.
The platform will allow life sciences researchers and informatics professionals to quickly aggregate, access and analyse research data from multiple applications. Data will now be accessible through a single set of interfaces, with integrated workflow, reporting and analytics capabilities. Incorporating a modern user interface and a secure, multi-tenant environment, the platform will unify user experience elements and enable easier collaboration across the research and development (R&D) enterprise, including with external partners.
Merck is collaborating with Accenture on this launch and will be the first pharmaceutical company to use the platform.
The platform is available to pharmaceutical, biotech and scientific research organisations that are seeking unique approaches to solve research informatics challenges.
Click here for the complete issue.